Calvin J. Gordon
About
In The Last Decade
Calvin J. Gordon
11 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 103
- Infectious Diseases 1.5k
- Molecular Biology 392
- Computational Theory and Mathematics 268
- Neurology 225
- Cardiology and Cardiovascular Medicine 201
Countries citing papers authored by Calvin J. Gordon
This map shows the geographic impact of Calvin J. Gordon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Calvin J. Gordon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Calvin J. Gordon more than expected).
Fields of papers citing papers by Calvin J. Gordon
This network shows the impact of papers produced by Calvin J. Gordon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Calvin J. Gordon. The network helps show where Calvin J. Gordon may publish in the future.
Co-authorship network of co-authors of Calvin J. Gordon
This figure shows the co-authorship network connecting the top 25 collaborators of Calvin J. Gordon. A scholar is included among the top collaborators of Calvin J. Gordon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Calvin J. Gordon. Calvin J. Gordon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 4 | |
| 3 | Mutations in the SARS-CoV-2 RNA-dependent RNA polymerase confer resistance to remdesivir by distinct mechanisms breakdown → | 139 |
| 4 | 23 | |
| 5 | 13 | |
| 6 | Molnupiravir promotes SARS-CoV-2 mutagenesis via the RNA template breakdown → | 212 |
| 7 | 25 | |
| 8 | 2 | |
| 9 | 11 | |
| 10 | Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency breakdown → | 698 |
| 11 | 117 | |
| 12 | The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus breakdown → | 621 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.